No Data
Adit (301580.SZ): The zirconia products produced by the company can make 15-20 dental crowns per piece.
On December 11, Gelonghui reported that Aidi Te (301580.SZ) stated on the investor interactive platform that the zirconia products produced by the company can be used to make 15-20 dental crowns per piece. For clinical patients, paying the corresponding diagnosis and treatment fees to receive treatment will allow them to enjoy comprehensive Medical Services, and the related costs cannot be simply compared to the price of dental crowns. The company's main sales product, zirconia ceramics, is an upstream material for dental crowns. Currently, the centralized procurement policy for implants is still limited to the implants, rather than the upstream materials for crowns. In addition, considering that the cost of crowns accounts for a relatively low proportion of the dental implant expenses, it is expected that the centralized procurement policy for implants will affect the company.
Editt: Third quarter report 2024
Aidite (301580.SZ): The net income in the first three quarters was 0.111 billion yuan, a year-on-year increase of 12.71%.
Adtech (301580.SZ) announced on October 27th that it achieved revenue of 0.641 billion yuan in the first three quarters of 2024, a year-on-year growth of 14.09%; net income attributable to the listed company's shareholders was 0.111 billion yuan, a year-on-year growth of 12.71%, with basic earnings per share of 1.75 yuan.
EdiTech (301580.SZ) released its performance for the first three quarters, with a net income of 0.111 billion yuan, a year-on-year increase of 12.71%.
Edith (301580.SZ) released the third quarter report for 2024, with revenue for the first three quarters of the company at 6.4...
Aidite (301580.SZ): As of the end of 2023, the proportion of the R&D team reached 14.64%, and R&D innovation investment has been increasing year by year.
Gelonghui, Oct. 14th - Edith (301580.SZ) stated on the investor interaction platform that the company has been shortlisted for the sixth batch of national specialized, special, and new "little giant" enterprise public announcement list, and was publicly announced in early September 2024. The company focuses on casting specialty, enhancing industrial matching, and winning the market through innovation. By the end of 2023, the research and development team accounted for 14.64%, with annual increases in research and development innovation investment. After more than 10 years of technological accumulation and product iteration, starting from 2021, the company has successively won the first prize of the Beijing Science and Technology Award, the Geneva Invention Gold Award, and other honors, and has obtained the national key research and development program "diagnosis".
Individual Investors Who Hold 35% of Aidite (Qinhuangdao) Technology Co., Ltd. (SZSE:301580) Gained 27%, Insiders Profited as Well
No Data
